For example, small molecule drug conjugates comprised of an acetazolamide derivative linked to the maytansinoid DM1 were found to accumulate in CAIX-positive lesions and have antitumor effects using the SKRC52 renal cell carcinoma model (Krall et al., 2014). The gene discussed is CA9; the disease is hereditary clear cell renal cell carcinoma.